Nephrocare Health Services Limited (NSE:NEPHROPLUS)
India · Delayed Price · Currency is INR 620.55
-9.85 (-1.56%)
Nov 12, 2026, 3:29 PM IST
NSE:NEPHROPLUS Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, NSE:NEPHROPLUS stock has a consensus rating of "Strong Buy" and an average price target of ₹798.00. The average 1-year stock price forecast is 28.60% higher than the current stock price, while the lowest is ₹730.00 (+17.64%) and the highest is ₹920.00 (+48.26%).
Price Target: ₹798.00 (+28.60%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NSE:NEPHROPLUS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 4 | 4 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 5 |
Financial Forecast
Revenue This Year
12.25B
from 9.99B
Increased by 22.59%
Revenue Next Year
14.79B
from 12.25B
Increased by 20.81%
EPS This Year
14.20
from 8.10
Increased by 75.33%
EPS Next Year
18.57
from 14.20
Increased by 30.77%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.